Elenoside increases intestinal motility

Figure 1 Percentage increase in water of boluses in vehicle control, elenoside, and cisapride. Values are mean ± SE for 10 rats/group. ^aP < 0.05 vs control.

Figure 2 Small intestinal transit (SIT) in vehicle control and elenoside-treated and cisapride-treated animals. Values are mean ± SE for 10 rats/group. ^aP < 0.05 vs control.

Figure 3 Codeine phosphate induced delay in small intestinal transit (SIT) in vehicle control, elenoside, and cisapride groups. Values are mean ± SE for 10 rats/group. ^aP < 0.05 vs control.

Figure 4 A: Time-course of the effects of elenoside and cisapride on contraction force in rat duodenum vs baseline. Values are mean ± SE for 10 duodenum samples during 6 min; ^aP < 0.05. B: Time-course of the effects of elenoside and cisapride on contraction force in rat jejunum vs baseline. Values are mean ± SE for 10 jejunum samples during 6 min; ^aP < 0.05. C: Time-course of the effects of elenoside and cisapride on contraction force in rat ileum vs baseline. Values are mean ± SE for 10 ileum samples during 6 min; ^aP < 0.05.

Figure 5 A: Time-course of the effects of elenoside and cisapride on intestinal frequency in the rat duodenum vs baseline. Values are mean ± SE for 10 duodenum samples during 6 min; ^aP < 0.05. B: Time-course of the effects of elenoside and cisapride on intestinal frequency in the rat jejunum vs baseline. Values are mean ± SE for 10 jejunum samples during 6 min; ^aP < 0.05. C: Time-course of the effects of elenoside and cisapride on intestinal frequency in the rat ileum vs baseline. Values are mean ± SE for 10 ileum samples during 6 min; ^aP < 0.05.